Abstract
Neuropsychological assessment may identify mild deficits in HIV-infected persons, but it is sometimes unclear if such deficits compromise functional competencies, such as the ability to adhere to complex medication regimens. We examined the relationship between neuropsychological status (NP), observed performance on a medication management test (MMT), and antiviral medication adherence as elicited in a 3-day recall measure. Two samples of HIV+ subjects (n = 20, n = 41) were used to develop and validate the MMT. An additional 57 HIV+ patients taking antivirals were assessed to examine NP, MMT, and adherence outcomes. NP performance was scored according to age- and education-based norms. Adherence was assessed by comparing reported medication use to medication insert information. Poorer performance on the MMT was associated with scores <−1 SD below norms in tests of memory (RAVLT), executive function (Odd Man Out), and psychomotor skill (Grooved Pegboard). Half the sample made >1 adherence error, as reported in the recall measure. Number of errors was related to both NP and MMT performance. Deficits identified in NP assessment and captured in an observed performance test of medication management are related to HIV medication adherence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Academy of Neurology AIDS Task Force. (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology, 41, 778–785.
Albert, S. M., Marder, K., Dooneief, G., Bell, K., Sano, M., Todak, G., and Stern, Y. (1995). Neuropsychologic impairment in early HIV infection: A risk factor for work disability. Archives of Neurology, 52, 525–530.
Albert, S. M., Todak, G., Elkin, E., Marder, K., Dooneief, G., and Stern, Y. (1994). Time allocation and disability in HIV infection: A correlational study. Journal of Occupational Science, 1, 21–30.
Alwood, K., Keruly, J., Moore-Rice, K., Stanton, D. L., Chaulk, C. P., and Chaisson, R. E. (1994). Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients. AIDS, 8, 1103–1108.
Bacellar, H., Munoz, A., Miller, E. N., Cohen, B. A., Besley, D., Selnes, O. A., Becker, J. T., and McArthur, J. C. (1994). Temporal trends in the incidence of HIV-1 related neurologic diseases: Multi-Center AIDS Cohort Study, 1985–1992. Neurology, 44, 1892–1900.
Benton, A. L. (1951). The Visual Retention Test. New York: The Psychological Corporation.
Blaschke, T. F. (1997). Noncompliance and resistance to protease inhibitors. Presented at the 4th Conference on Retroviruses and Opportunistic Infections.
Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., and Volberding, P. A. (1997). Antiretroviral therapy for HIV infection in 1997: Updated recommendations of the International AIDS Society—USA Panel. Journal of the American Medical Association, 277, 1962–1969.
Concha, M., Selnes, O. A., McArthur, J., Nance-Sproson, T., Updike, M. L., Royal, W., Solomon, L., and Vlahov, D. (1995). Normative data for a brief neuropsychological test battery in a cohort of injecting drug users. International Journal of the Addictions, 30, 832–841.
Condra, J. H., Schleif, W., Blahy, O., Gabryelski, L. J., Graham, D. J., Quintero, J. C., Rhodes, A., Robbins, H. L., Roth, E., and Shivaprakesh, M. (1995). In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature, 374, 569–571.
Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders. (1996). Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. Neurology, 47, 1247–1253.
Deeks, S. G., Smith, M., Holodney, M., and Kahn, J. (1997). HIV-1 protease inhibitors: A review for clinicians. Journal of the American Medical Association, 277, 145–153.
Delis, D. C., Kramer, J. H., Kaplan, E., and Ober, B. A. (1983). California Verbal Learning Test. San Antonio, TX: The Psychological Corporation.
Diehl, M., Willis, S. L., and Schaie, K. W. (1995). The observed tasks of daily living (OTDL) test. Psychology and Aging, 10, 478–491.
Flowers, K. A., and Robertson, C. (1985). The effects of Parkinson's disease on the ability to maintain a mental set. Journal of Neurology, Neurosurgery, and Neuropsychiatry, 48, 517–529.
Galetko, S. M., Segarra, M., Ravin, D. S., and Babich, M. P. (1996). Zidovudine compliance as measured by different methods in an HIV ambulatory clinic. Journal of Pharmacy Technology, 12, 105–108.
Kløve, H. (1963). Clinical neuropsychology. Medical Clinics of North America, 46, 1647–1658.
McArthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., Cohen, B. A., Becker, J. T., Graham, N. M. H., McArthur, J. H., Selnes, O. A., Jacobson, L. P., Visscher, B. R., Concha, M., Saah, A., and MACS Cohort (1993). Dementia in AIDS patients: Incidence and risk factors. Neurology, 34, 2245–2252.
Miller, E. N., Satz, P., and Visscher, B. (1991). Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology, 41, 1608–1616.
Muma, R. D., Ross, M. W., Parcel, G. S., and Pollard, R. B. (1995). Zidovudine adherence among individuals with HIV infection. AIDS Care, 7, 439–447.
Pablos-Mendez, A., Knirsch, C. A., Barr, R. G., Lerner, B. H., and Frieden, T. R. (1997). Nonadherence in tuberculosis treatment: Predictors and consequences in New York City. American Journal of Medicine, 102, 164–170.
Rabkin, J. G., and Chesney, M. (1999). Treatment adherence to HIV medications: The Achilles heel of the new therapeutics. In D. Ostrow and S. Kalichman (Eds.), New HIV therapies: Psychological and public health implications. New York: Plenum Press.
Rey, A. (1941). L'examen psychologique dans las cas d'encephalopathie traumatique. Archives de Psychologie, 28, 286–340.
Samet, J. H., Libyan, H., Steger, K. A., Dhawan, R. K., Chen, J., Shevitz, A. B., Dewees-Dunk, R., Levenson, S., Kufe, D., and Craven, D. (1992). Compliance with zidovudine therapy in patients infected with immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic. American Journal of Medicine, 92, 495–502.
Selnes, O. A., Jacobson, L., Machado, A. M., and MACS Cohort (1993). Normative data for a brief neuropsychological screening battery. Perceptual and Motor Skills, 73, 539–550.
Stall, R., Hoff, C., Coates, T. J., Paul, J., Phillips, K. A., Ekstrand, M., Kegeles, S., Catania, J., Daigle, D., and Diaz, R. (1996). Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: Implications for secondary prevention. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11, 151–160.
Todak, G., Polanco, C., Winston, T., and Albert, S. M. (1996). Effect of HIV-1 associated dementia on daily function. Presented at XI International Conference on AIDS, Vancouver, Canada.
Ungvarski, P. J., and Rottner, J. E. (1997). Errors in prescribing HIV-1 protease inhibitors. Journal of the Association of Nurses and AIDS Care 8, 55–61.
Wall, T. L., Sorensen, J. L., Batki, S. L., Delucchi, K. L., London, J. A., and Chesney, M. A. (1995). Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug and Alcohol Dependence, 37, 261–269.
Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised. New York: The Psychological Corporation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Albert, S.M., Weber, C.M., Todak, G. et al. An Observed Performance Test of Medication Management Ability in HIV: Relation to Neuropsychological Status and Medication Adherence Outcomes. AIDS Behav 3, 121–128 (1999). https://doi.org/10.1023/A:1025483806464
Issue Date:
DOI: https://doi.org/10.1023/A:1025483806464